Retatrutide is a innovative treatment generating substantial buzz in the weight loss field. This remarkable peptide, developed by Eli Lilly, functions as a dual GIP and GLP-1 target agonist. Essentially, it replicates the action of these natural hormones, which regulate appetite and promote a sen